For example, in metastatic and therapeutic-resistant breast cancer patient samples, EGFR/HER1 is not restricted to the cell surface, but instead can be found intracellularly in both endocytic organelles and the nucleus [2, 3]. Here, EGFR is linked to breast cancer.